Risk of death from breast cancer after treatment for ductal carcinoma in situ. BJS 2017; 104: 1506-1513.
Published: 22nd August 2017
Authors: C. Wadsten, H. Garmo, I. Fredriksson, M. Sund, F. Wärnberg
Studies to date have failed to demonstrate any survival benefit from preventing local recurrence after treatment for ductal breast carcinoma
A nested case–control study was conducted in a population‐based cohort of women with primary
From a cohort of 6964 women, 96 who died from breast cancer were identified and these were compared with a group of 318 controls. Tumour size over 25 mm or multifocal
In the present study, large tumour size and positive or uncertain margin status were associated with a higher risk of death from breast cancer after treatment for primary
You may also be interested in
Authors: E. Botteri, P. Veronesi, J. Vila, N. Rotmensz, V. Galimberti, M. V. Thomazini et al.
Notes: Molecular subtype matters more
Nomograms for preoperative prediction of axillary nodal status in breast cancer. BJS 2017; 104: 1494-1505.
Authors: L. Dihge, P.‐O. Bendahl, L. Rydén
Notes: Defines need for staging?
Authors: J. R. Benson, S. K. Down
Authors: R. V. Dave, R. Millican‐Slater, D. Dodwell, K. Horgan, N. Sharma
Notes: Mid‐neoadjuvant chemotherapy MRI useful
Combined PET–CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node‐positive breast cancer after neoadjuvant therapy. BJS 2017; 104: 1188-1196.
Authors: B. B. Koolen, M. Donker, M. E. Straver, M. E. M. van der Noordaa, E. J. T. Rutgers, R. A. Valdés Olmos et al.
Notes: Reduced axillary lymph node dissection rates
Quality of life after mastectomy with or without immediate breast reconstruction. BJS 2017; 104: 1197-1206.
Authors: J. Dauplat, F. Kwiatkowski, P. Rouanet, E. Delay, K. Clough, J. L. Verhaeghe et al.
Notes: Good for the appropriate patient
Authors: C. Liedtke, H.‐C. Kolberg
Association between age and access to immediate breast reconstruction in women undergoing mastectomy for breast cancer. BJS 2017; 104: 555-561.
Authors: R. Jeevan, J. P. Browne, C. Gulliver‐Clarke, J. Pereira, C. M. Caddy, J. H. P. van der Meulen et al.
Notes: Age should not matter
Ten‐year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study. BJS 2017; 104: n/a-n/a.
Authors: J. de Boniface, J. Frisell, L. Bergkvist, Y. Andersson
Notes: Axillary recurrences rare
Authors: K.‐T. Lee, S. I. Bang, J.‐K. Pyon, J. H. Hwang, G.‐H. Mun
Notes: Implants increase risk
Meta‐analysis of sentinel lymph node biopsy in breast cancer using the magnetic technique. BJS 2016; 103: 1409-1419.
Authors: A. Zada, M. C. L. Peek, M. Ahmed, B. Anninga, R. Baker, M. Kusakabe et al.
Notes: Both work
Authors: J. Brandt, S. Borgquist, M. Almquist, J. Manjer
Notes: Hypothyroidism reduces survival